Cocaine and human immunodeficiency virus type 1 gp120 mediate neurotoxicity through overlapping signaling pathways

被引:51
|
作者
Yao, Honghong [1 ]
Allen, James E. [1 ]
Zhu, Xuhui [1 ]
Callen, Shannon [1 ]
Buch, Shilpa [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA
关键词
gp120; cocaine; HIV-1-associated neurological disorders; neurotoxicity; primary neurons; NADPH OXIDASE; TRANSCRIPTION FACTORS; CHEMOKINE RECEPTOR; APOPTOSIS; ACTIVATION; PROTEIN; EXPRESSION; NEURONS; ERK; ENHANCEMENT;
D O I
10.1080/13550280902755375
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Although it has been well documented that drugs of abuse such as cocaine cause enhanced progression of human immunodeficiency virus (HIV)-associated neuropathological disorders, the underlying mechanisms mediating these effects remain poorly understood. The present study demonstrated that exposure of rat primary neurons to both cocaine and gp120 resulted in increased cell toxicity compared to cells treated with either factor alone. The combinatorial toxicity of cocaine and gp120 was accompanied by an increase in both caspase-3 activity and expression of the proapoptotic protein Bax. Furthermore, increased neurotoxicity in the presence of both the agents was associated with a concomitant increase in the production of intracellular reactive oxygen species and loss of mitochondrial membrane potential. Increased neurotoxicity mediated by cocaine and gp120 was ameliorated by NADPH oxidase inhibitor apocynin, thus underscoring the role of oxidative stress in this cooperation. Signaling pathways including c-jun N-teminal kinase (JNK), p38, extracellular signal-regulated kinase (ERK)/mitogen-activated protein kinases (MAPK), and nuclear factor (NF)-B were also identified to be critical in the neurotoxicity induced by cocaine and gp120. These findings thus underscore the role of oxidative stress, mitochondrial and MAPK signal pathways in cocaine and HIV gp120-mediated neurotoxicity.
引用
收藏
页码:164 / 175
页数:12
相关论文
共 50 条
  • [41] MUTATIONS IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP41 AFFECT SENSITIVITY TO NEUTRALIZATION BY GP120 ANTIBODIES
    BACK, NKT
    SMIT, L
    SCHUTTEN, M
    NARA, PL
    TERSMETTE, M
    GOUDSMIT, J
    [J]. JOURNAL OF VIROLOGY, 1993, 67 (11) : 6897 - 6902
  • [42] Immunization with an interferon-γ-gp120 fusion protein induces enhanced immune responses to human immunodeficiency virus gp120
    McCormick, AL
    Thomas, MS
    Heath, AW
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (11): : 1423 - 1430
  • [43] Human immunodeficiency virus type 1 gp120 induces apoptosis in human primary neurons through redox-regulated activation of neutral sphingomyelinase
    Jana, A
    Pahan, K
    [J]. JOURNAL OF NEUROSCIENCE, 2004, 24 (43): : 9531 - 9540
  • [44] Pattern of gp120 sequence divergence linked to a lack of clinical progression in human immunodeficiency virus type 1 infection
    Wang, WK
    Essex, M
    McLane, MF
    Mayer, KH
    Hsieh, CC
    Brumblay, HG
    Seage, G
    Lee, TH
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (13) : 6693 - 6697
  • [45] Neutralizing antibodies to human immunodeficiency virus type-1 gp120 induce envelope glycoprotein subunit dissociation
    Poignard, P
    Fouts, T
    Naniche, D
    Moore, JP
    Sattentau, QJ
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02): : 473 - 484
  • [46] Betulinic acid derivatives that target gp120 and inhibit multiple genetic subtypes of human immunodeficiency virus type 1
    Lai, Weihong
    Huang, Li
    Ho, Phong
    Li, Zhijun
    Montefiori, David
    Chen, Chin-Ho
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2008, 52 (01) : 128 - 136
  • [47] Human immunodeficiency virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine
    McFarland, EJ
    Borkowsky, W
    Fenton, T
    Wara, D
    McNamara, J
    Samson, P
    Kang, MH
    Mofenson, L
    Cunningham, C
    Duliege, AM
    Sinangil, F
    Spector, SA
    Jimenez, E
    Bryson, Y
    Burchett, S
    Frenkel, LM
    Yogev, R
    Gigliotti, F
    Luzuriaga, K
    Livingston, RA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 2001, 184 (10): : 1331 - 1335
  • [48] Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein
    Moore, JP
    Sodroski, J
    [J]. JOURNAL OF VIROLOGY, 1996, 70 (03) : 1863 - 1872
  • [49] Uptake of human immunodeficiency virus envelope protein gp120 by human trophoblast in culture
    Esterman, AL
    Finlay, TH
    Lee, JD
    Dancis, J
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 174 (01) : 49 - 54
  • [50] Immunogenicity of constrained monoclonal antibody A32-human immunodeficiency virus (HIV) env gp120 complexes compared to that of recombinant HIV type 1 gp120 envelope glycoproteins
    Liao, HX
    Alam, SM
    Mascola, JR
    Robinson, J
    Ma, BJ
    Montefiori, DC
    Rhein, M
    Sutherland, LL
    Scearce, R
    Haynes, BF
    [J]. JOURNAL OF VIROLOGY, 2004, 78 (10) : 5270 - 5278